Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial

Vera Popović, Martin Bidlingmaier, Moisés Mercado, +21

The Journal of Clinical Endocrinology & Metabolism

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide

Susan L. Samson, Lisa B. Nachtigall, Maria Fleseriu, +13

The Journal of Clinical Endocrinology & Metabolism

A phase II study of laquinimod in Crohn's disease

Geert D’Haens, William J. Sandborn, Jean‐Frédéric Colombel, +6

Gut

Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly

Christian J. Strasburger, Niki Karavitaki, Sylvère Störmann, +12

European Journal of Endocrinology

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial

Maria Fleseriu, Alexander Dreval, Irina Bondar, +14

The Lancet Diabetes & Endocrinology

AllergyInjectable Somatostatin ReceptorClinical TrialsEndocrinologyMedicine +1

Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice

Eliza B. Geer, Jill Sisco, Daphne T. Adelman, +6

BMC Endocrine Disorders

CO2 laser in oral graft-versus-host disease: a pilot study

Reuven Or, M Y Shapira, Asi Haviv, +4

Bone Marrow Transplantation

Oral CavitySurgeryCo2 LaserMedicineOral Cancer

Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider

Eliza B. Geer, Jill Sisco, Daphne T. Adelman, +6

Pituitary

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands

Maria Fleseriu, Mark E. Molitch, Alexander Dreval, +7

Frontiers in Endocrinology

An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies

Maria Fleseriu, Leon Fogelfeld, Murray B. Gordon, +5

Pituitary